Carrie E. Carlander
2006
In 2006, Carrie E. Carlander earned a total compensation of $645K as former Chief Financial Officer at Mast Therapeutics.
Compensation breakdown
| Option Awards | $170,397 |
|---|---|
| Salary | $138,462 |
| Stock Awards | $196,674 |
| Other | $139,502 |
| Total | $645,035 |
Carlander received $196.7K in stock awards, accounting for 30% of the total pay in 2006.
Carlander also received $170.4K in option awards, $138.5K in salary and $139.5K in other compensation.
Rankings
In 2006, Carrie E. Carlander's compensation ranked 4,060th out of 7,022 executives tracked by ExecPay. In other words, Carlander earned more than 42.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,060 out of 7,022 | 42nd |
Division Manufacturing | 1,341 out of 2,413 | 44th |
Major group Chemicals And Allied Products | 326 out of 673 | 52nd |
Industry group Drugs | 216 out of 518 | 58th |
Industry Pharmaceutical Preparations | 161 out of 355 | 55th |
Source: SEC filing on April 17, 2007.
Carlander's colleagues
We found six more compensation records of executives who worked with Carrie E. Carlander at Mast Therapeutics in 2006.
2006
James Merritt
Mast Therapeutics
Chief Medical Officer
2006
Joan Robbins
Mast Therapeutics
Chief Scientific Officer
2006
Evan Levine
Mast Therapeutics
Chief Executive Officer
2006
Brian Culley
Mast Therapeutics
Chief Business Officer
2006
Robert Daniel
Mast Therapeutics
Chief Financial Officer
2006
Gregory Hanson
Mast Therapeutics